Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CytomX Therapeutics (CTMX) Construction in Progress (2017 - 2023)

Historic Construction in Progress for CytomX Therapeutics (CTMX) over the last 7 years, with Q4 2023 value amounting to $368000.0.

  • CytomX Therapeutics' Construction in Progress fell 4780.14% to $368000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $368000.0, marking a year-over-year decrease of 4780.14%. This contributed to the annual value of $368000.0 for FY2023, which is 4780.14% down from last year.
  • Per CytomX Therapeutics' latest filing, its Construction in Progress stood at $368000.0 for Q4 2023, which was down 4780.14% from $705000.0 recorded in Q4 2022.
  • CytomX Therapeutics' 5-year Construction in Progress high stood at $705000.0 for Q4 2022, and its period low was $236000.0 during Q4 2019.
  • Its 5-year average for Construction in Progress is $373800.0, with a median of $308000.0 in 2021.
  • Its Construction in Progress has fluctuated over the past 5 years, first tumbled by 6993.63% in 2019, then skyrocketed by 12889.61% in 2022.
  • Quarter analysis of 5 years shows CytomX Therapeutics' Construction in Progress stood at $236000.0 in 2019, then rose by 6.78% to $252000.0 in 2020, then increased by 22.22% to $308000.0 in 2021, then surged by 128.9% to $705000.0 in 2022, then crashed by 47.8% to $368000.0 in 2023.
  • Its Construction in Progress was $368000.0 in Q4 2023, compared to $705000.0 in Q4 2022 and $308000.0 in Q4 2021.